CD300LG抗体CD300LG兔多抗抗体Triggerin
g receptor expressed on myeloid cells 4 antibody抗体CD300LG Antibody, Biotin conjugated抗体- ￥880 - 1320
- CUSABIO
- CN
- CSB-PA751016LD01HU
- 2025年07月12日
- ELISA
- Rabbit
- Human
企业认证
相关产品推荐更多 >
B4GALT3抗体B4GALT3一抗抗体UDP-galactose:beta-N-acetylglucosamine beta-1 antibody抗体B4GALT3 Antibody抗体
￥3900
HPS1抗体HPS1兔多抗抗体MGC5277 antibody抗体HPS1 Antibody抗体
￥440
ITGAM抗体ITGAM兔多抗抗体SLEB6 antibody抗体ITGAM Antibody, Biotin conjugated抗体
￥880
HOPX抗体HOPX一抗抗体TOTO antibody抗体HOPX Antibody抗体
￥3900ACP6抗体ACP6兔多抗抗体PPA6_HUMAN antibody抗体ACP6 Antibody抗体
￥440
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Human CMRF35-like molecule 9 protein (128-241AA)
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性：
Polyclonal
- 标记物：
Biotin
- 适应物种：
Human
- 保质期：
6个月
- 抗原来源：
Homo sapiens (Human)
- 目录编号：
Q6UXG3
- 级别：
优
- 库存：
200
- 供应商：
武汉华美生物工程有限公司
- 宿主：
Rabbit
- 应用范围：
ELISA
- 浓度：
>95%,Protein G purified
- 靶点：
CD300LG
- 抗体英文名：
CD300LG Antibody, Biotin conjugated
- 抗体名：
Triggering receptor expressed on myeloid cells 4 antibody
- 规格：
100μg/50μg
| 规格： | 100μg | 产品价格： | ￥1320.0 |
|---|---|---|---|
| 规格： | 50μg | 产品价格： | ￥880.0 |
保存缓冲液
Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
功能
Receptor which may mediate L-selectin-dependent lymphocyte rollings. Binds SELL in a calcium dependent manner. Binds lymphocyte (By similarity).风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Uptake of Antigen-Antibody Complexes by Human Dendritic Cells
Fc receptors specific for IgG (FcγR) potentiate the immune response by facilitating the interaction between myeloid cells and antibody-coated targets (1 -3 ). Monocyte and neutrophil FcyR engagement can lead to the induction of lytic-type
Cytotoxic Tumor Targeting With scFv Antibody-Modified Liposomes
Specific targeting of liposome-formulated cytotoxic drugs or antigens to receptors expressed selectively on target cells represents an effective strategy for increasing the pharmacological efficacy of the delivered molecules
Chimerization of a Monoclonal Antibody for Treating Hodgkin's Lymphoma
Ber-H2 which recognizes the human CD30 molecule with high specificity and affinity (2 ). CD30, a member of the nerve growth factor (NGF) tumor necrosis factor receptor (TNFR) superfamily (3 ), is strongly expressed on the pathognomonic Hodgkin (H
技术资料暂无技术资料 索取技术资料
